Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

KIWI Study Group, Jane C Davies, Steve Cunningham, William T Harris, Allen Lapey, Warren E Regelmann, Gregory S Sawicki, Kevin W Southern, Sarah Robertson, Yulia Green, Jon Cooke, Margaret Rosenfeld

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study'. Together they form a unique fingerprint.

Medicine & Life Sciences